SUNDAY, April 14 (HealthDay News) -- For the first time,
scientists have been able to bioengineer an animal kidney and see
it work in a living animal, in what they hope is a step toward
creating organs for people with failing kidneys.
A kidney transplant is the only cure for people with advanced
kidney failure, but there aren't enough donor organs to meet the
need. In the United States, nearly 1 million people have end-stage
kidney disease, and there are currently more than 95,000 on the
waiting list for a donor organ, according to data from the United
Network for Organ Sharing.
In the new study, researchers at Harvard and Massachusetts
General Hospital created a replacement kidney that, when
transplanted into rats, immediately began producing urine as a
normal kidney would.
The artificial organ could not match the full function of a
normal kidney, but experts said the findings are a promising step
toward creating replacement kidneys for people.
"These results are really quite impressive," said Dr. Mala Sachdeva, a kidney specialist who was not involved in the research. "The transplanted tissue was actually functional."
The findings, released early online April 14 by the journal
Nature Medicine, "offer great promise," said Sachdeva, a
nephrologist at North Shore University Hospital Transplant Center
in Manhasset, N.Y.
However, she stressed, "it's very early to get our hopes up too
high. A lot more work needs to be done."
Senior researcher Dr. Harald Ott agreed that years of study
"This study really just shows a proof of principle," said Ott, of Harvard Medical School and the Center for Regenerative Medicine at Massachusetts General Hospital.
In an "ideal world," Ott said, scientists would someday be able
to create new kidneys "on demand" from kidney failure patients' own
body cells. That could potentially not only ease donor organ
shortages, but also address the problem of organ rejection, both
Ott and Sachdeva said.
Right now, doctors try to find donor kidneys that match a
patient's genetic profile as closely as possible. Even so,
transplant recipients have to remain on drugs that suppress the
immune system, to lower the likelihood of an immune system attack
on the foreign organ.
And those drugs, Sachdeva noted, come with side effects --
including a higher susceptibility to infections or, over time,
cancer. Some immunosuppressants can cause conditions such as bone
disease, high blood pressure or cataracts.
Finding a way to create kidneys from patients' own cells could
limit the need for those drugs, according to Ott. But first, the
researchers have to figure out how to "scale up" this technology to
humans, he said.
Ott's team engineered the replacement kidneys by first stripping
rat kidneys of their "living cells," using a detergent solution.
That left behind a collagen "scaffold" that the researchers
repopulated with kidney cells from newborn rats, as well as human
cells that were used to replace the lining of the kidney blood
The organs were then cultured in the lab before being
transplanted into rats that had one kidney removed. Ott's team
found that the engineered kidneys were able to produce urine.
There are still plenty of questions about how this would be
translated to humans, according to Ott. One is, where would the
kidney "scaffolds" come from? You could use kidneys from cadavers,
Ott said -- but then there would still be a need for donor organs.
It's also unclear if a patient's immune system would react against
the foreign scaffold, even with his or her own cells repopulating
Ott's team has already found that human and pig kidneys can be
stripped of their cells to form a scaffold. It's possible, Ott
said, that pig kidneys could be used to form the scaffold for human
There's also the question of what cell types from patients would
work. Can patients' blood cells, for instance, be coaxed into
becoming mature kidney cells?
Ott said it's hard to estimate how long it will take to answer
those questions. "But if this technology works out, clinical
application will be years away," he said. Still, he added, "I think
there's room for cautious optimism."
Learn more about
transplantsfrom the United Network for Organ Sharing.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.